Danielsson Kim Christian, Borthen Ingrid, Morken Nils-Halvdan, Gilhus Nils Erik
Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway.
Department of Clinical Medicine, University of Bergen, Bergen, Norway.
BMJ Open. 2018 Apr 24;8(4):e020998. doi: 10.1136/bmjopen-2017-020998.
To estimate the risk of hypertensive pregnancy complications in women with epilepsy, with and without antiepileptic drugs, and assess the risk associated with the four most common antiepileptic drugs.
A population-based cohort study using linked data from the Medical Birth Registry of Norway and the Norwegian Prescription Database. Women with epilepsy with and without antiepileptic drugs were compared with women without epilepsy.
Norway, 2004-2012.
All first pregnancies of women with epilepsy and women without epilepsy were included.
Main outcome measures were hypertensive pregnancy complications: a compound variable of any hypertensive disorder, gestational hypertension, mild pre-eclampsia, severe pre-eclampsia, early onset pre-eclampsia, eclampsia and HELLP syndrome (haemolysis, elevated liver enzymes, low platelets).
In total, 1778 pregnancies in women with epilepsy and 221 662 in women without epilepsy were analysed. 682 of the women with epilepsy used antiepileptic drugs, the most common in monotherapy being: lamotrigine (n=280), carbamazepine (n=94), levetiracetam (n=71) and valproate (n=51). There was an increased risk of any hypertensive disorder in women with epilepsy (adjusted OR (aOR) 1.2, 95% CI 1.0 to 1.5) and in the subcategory using valproat (aOR 2.9, 95% CI 1.3 to 6.4). The most frequent hypertensive complication was mild pre-eclampsia and the risk was increased in women with epilepsy (aOR 1.4, 95% CI 1.1 to 1.8) and women with epilepsy with valproat (aOR 3.3, 95% CI 1.2 to 9.4).
Women with epilepsy have an increased risk of mild pre-eclampsia, but not for the severe types of hypertensive pregnancy complications. Lamotrigine and levetiracetam do not predispose for mild pre-eclampsia, whereas valproate was associated with an increased risk of mild pre-eclampsia.
评估患癫痫女性使用或未使用抗癫痫药物时发生高血压妊娠并发症的风险,并评估四种最常用抗癫痫药物相关的风险。
一项基于人群的队列研究,使用挪威医疗出生登记处和挪威处方数据库的关联数据。将患癫痫且使用或未使用抗癫痫药物的女性与未患癫痫的女性进行比较。
挪威,2004 - 2012年。
纳入所有患癫痫女性和未患癫痫女性的首次妊娠。
主要结局指标为高血压妊娠并发症:包括任何高血压疾病、妊娠期高血压、轻度子痫前期、重度子痫前期、早发型子痫前期、子痫和HELLP综合征(溶血、肝酶升高、血小板减少)的复合变量。
共分析了1778例患癫痫女性的妊娠情况和221662例未患癫痫女性的妊娠情况。682例患癫痫女性使用了抗癫痫药物,单药治疗中最常用的是:拉莫三嗪(n = 280)、卡马西平(n = 94)、左乙拉西坦(n = 71)和丙戊酸盐(n = 51)。患癫痫女性发生任何高血压疾病的风险增加(调整后比值比(aOR)1.2,95%置信区间1.0至1.5),使用丙戊酸盐的亚组中风险增加(aOR 2.9,95%置信区间1.3至6.4)。最常见的高血压并发症是轻度子痫前期,患癫痫女性(aOR 1.4,95%置信区间1.1至1.8)和使用丙戊酸盐的患癫痫女性(aOR 3.3,95%置信区间1.2至9.4)的风险增加。
患癫痫女性发生轻度子痫前期的风险增加,但重度高血压妊娠并发症的风险未增加。拉莫三嗪和左乙拉西坦不会诱发轻度子痫前期,而丙戊酸盐与轻度子痫前期风险增加相关。